Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Boston Scientific ( (BSX) ) just unveiled an update.
Boston Scientific held its 2026 annual meeting of stockholders on April 30, 2026, in a virtual-only webcast format, where shareholders elected all 10 director nominees to one-year terms and approved, on an advisory basis, the compensation of the company’s named executive officers. Investors also ratified Ernst & Young LLP as the independent auditor for fiscal 2026, approved an increase in shares under the Employee Stock Purchase Plan, and backed charter amendments removing supermajority voting and adding officer exculpation, while rejecting both management and shareholder proposals to give investors the right to call special meetings, preserving current limits on shareholder-initiated governance actions.
The most recent analyst rating on (BSX) stock is a Buy with a $96.00 price target. To see the full list of analyst forecasts on Boston Scientific stock, see the BSX Stock Forecast page.
Spark’s Take on BSX Stock
According to Spark, TipRanks’ AI Analyst, BSX is a Neutral.
The score is supported primarily by strong multi-year financial execution and improved profitability, plus a generally constructive (but cautious) earnings outlook. It is held back by weak technical trend signals and a high P/E valuation, alongside near-term operational and margin headwinds cited on the latest earnings call.
To see Spark’s full report on BSX stock, click here.
More about Boston Scientific
Boston Scientific is a global medical technology company that develops and manufactures devices used in a wide range of interventional medical specialties, including cardiology, endoscopy, urology and neuromodulation. The company focuses on minimally invasive therapies that aim to improve patient outcomes and reduce healthcare costs, giving it a significant presence in hospitals and specialty care markets worldwide.
Average Trading Volume: 16,375,920
Technical Sentiment Signal: Sell
Current Market Cap: $84.5B
For a thorough assessment of BSX stock, go to TipRanks’ Stock Analysis page.